140 related articles for article (PubMed ID: 9690967)
1. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
Wehnert A
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
[TBL] [Abstract][Full Text] [Related]
2. EPOS: Increasing our understanding of the treatment of schizophrenia; Start of a prospective referenced cohort study of sertindole in clinical practice.
Wehnert A; Hale A; Kasper S; Moller HJ; Campbell R; Stilwell C; Sloth-Nielsen M
Int J Psychiatry Clin Pract; 1997; 1(3):197-202. PubMed ID: 24940835
[TBL] [Abstract][Full Text] [Related]
3. The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
Kasper S; Möller HJ; Hale A
Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):59-68. PubMed ID: 19455275
[TBL] [Abstract][Full Text] [Related]
4. Do we need another atypical antipsychotic?
Kasper S
Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
[TBL] [Abstract][Full Text] [Related]
5. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
6. The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology.
Peuskens J; Tanghøj P; Mittoux A;
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):425-33. PubMed ID: 18384186
[TBL] [Abstract][Full Text] [Related]
7. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
8. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
9. [Problems in evaluating new antipsychotic drugs].
Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
[TBL] [Abstract][Full Text] [Related]
10. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
11. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
12. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
Jukić MK; Drmić S; Mimica N
Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
Bech P; Tanghøj P; Andreasson K; Overø KF
Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
[TBL] [Abstract][Full Text] [Related]
14. Sertindole : a review of its use in schizophrenia.
Murdoch D; Keating GM
CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
[TBL] [Abstract][Full Text] [Related]
15. Sertindole: dilemmas for its use in clinical practice.
Pae CU
Expert Opin Drug Saf; 2013 May; 12(3):321-6. PubMed ID: 23432404
[TBL] [Abstract][Full Text] [Related]
16. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
Brown LA; Levin GM
Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
[TBL] [Abstract][Full Text] [Related]
17. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
[TBL] [Abstract][Full Text] [Related]
18. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
19. Case histories illustrating the utility of sertindole in clinical practice.
Schuck P; van den Ameele H; Jaanson P; Ryckmans V; Hawley C
CNS Drugs; 2004; 18 Suppl 2():31-40; discussion 41-3. PubMed ID: 15461314
[TBL] [Abstract][Full Text] [Related]
20. Effect of sertindole on QTc interval in patients with schizophrenia.
Atmaca M; Yavuzkir M; Mermi O; Topuz M; Kanmaz E; Tezcan E
Neurosci Lett; 2008 Sep; 442(1):1-3. PubMed ID: 18639380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]